Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by tylerreddickon Jun 18, 2024 7:46pm
63 Views
Post# 36095114

RE:RE:This sounds pretty good to me

RE:RE:This sounds pretty good to me" In the quest to combat age-related skin concerns, we believe two groundbreaking topical agents, Pitera™ and GlycoProteMim™, will emerge as potential frontrunners. Both Pitera™ and GlycoProteMim™ represent significant strides in the field of dermatology, offering promising solutions to age-related skin issues. Pitera™, with its nutrient-rich profile, enhances skin vitality and youthfulness, while GlycoProteMim™ brings robust anti-aging effects inspired by nature's own survival mechanisms. As research progresses, the synergistic incorporation of these ingredients could potentially redefine the standards of topical treatments for age-related skin concerns, heralding a new era of youthful, resilient skin."
<< Previous
Bullboard Posts
Next >>